143 related articles for article (PubMed ID: 1565609)
1. Humanization of immunotoxins.
Rybak SM; Hoogenboom HR; Meade HM; Raus JC; Schwartz D; Youle RJ
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3165-9. PubMed ID: 1565609
[TBL] [Abstract][Full Text] [Related]
2. Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.
Rybak SM; Hoogenboom HR; Newton DL; Raus JC; Youle RJ
Cell Biophys; 1992; 21(1-3):121-38. PubMed ID: 1285324
[TBL] [Abstract][Full Text] [Related]
3. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
[TBL] [Abstract][Full Text] [Related]
4. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
5. Construction and expression of antibody-tumor necrosis factor fusion proteins.
Hoogenboom HR; Volckaert G; Raus JC
Mol Immunol; 1991 Sep; 28(9):1027-37. PubMed ID: 1922108
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
Newton DL; Nicholls PJ; Rybak SM; Youle RJ
J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
[TBL] [Abstract][Full Text] [Related]
7. Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice.
Newton DL; Pollock D; DiTullio P; Echelard Y; Harvey M; Wilburn B; Williams J; Hoogenboom HR; Raus JC; Meade HM; Rybak SM
J Immunol Methods; 1999 Dec; 231(1-2):159-67. PubMed ID: 10648935
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo.
Newton DL; Ilercil O; Laske DW; Oldfield E; Rybak SM; Youle RJ
J Biol Chem; 1992 Sep; 267(27):19572-8. PubMed ID: 1527074
[TBL] [Abstract][Full Text] [Related]
9. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin.
Yoon JM; Han SH; Kown OB; Kim SH; Park MH; Kim BK
Life Sci; 1999; 64(16):1435-45. PubMed ID: 10321723
[TBL] [Abstract][Full Text] [Related]
10. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
12. Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule.
Hoogenboom HR; Raus JC; Volckaert G
Biochim Biophys Acta; 1991 Jun; 1096(4):345-54. PubMed ID: 2065106
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins.
Rybak SM; Saxena SK; Ackerman EJ; Youle RJ
J Biol Chem; 1991 Nov; 266(31):21202-7. PubMed ID: 1939162
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of a chimeric antibody directed against the human transferrin receptor.
Hoogenboom HR; Raus JC; Volckaert G
J Immunol; 1990 Apr; 144(8):3211-7. PubMed ID: 2324499
[TBL] [Abstract][Full Text] [Related]
15. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
16. The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.
Qing Y; Shuo W; Zhihua W; Huifen Z; Ping L; Lijiang L; Xiaorong Z; Liming C; Daiwen X; Yu H; Wei X; Min F; Zuohua F; Guanxin S
Cancer Immunol Immunother; 2006 Sep; 55(9):1111-21. PubMed ID: 16341531
[TBL] [Abstract][Full Text] [Related]
17. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse.
Boado RJ; Zhang Y; Wang Y; Pardridge WM
Biotechnol Bioeng; 2009 Mar; 102(4):1251-8. PubMed ID: 18942151
[TBL] [Abstract][Full Text] [Related]
18. Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor.
Shen X; Hu GB; Jiang SJ; He FR; Xing W; Li L; Yang J; Zhu HF; Lei P; Shen GX
Protein Eng Des Sel; 2009 Dec; 22(12):723-31. PubMed ID: 19825853
[TBL] [Abstract][Full Text] [Related]
19. Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation.
Lei P; He Y; Ye Q; Zhu HF; Yuan XM; Liu J; Xing W; Wu S; Dai W; Shen X; Wang GB; Shen GX
Acta Pharmacol Sin; 2007 Oct; 28(10):1659-64. PubMed ID: 17883954
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell LA; Agrawal A; Ross DA; Muraszko KM
Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
